With the second wave of the Covid pandemic creating havoc across the country , a start-up based in Guwahati in Assam ~ Oxyfind ~ has devised a technological innovation to reduce crowds and maintain physical distance at vaccination centres…Just spare a few moments to know more about it….
Oxyfind helps in reducing crowds
Oxyfind is a technological health start-up launched by three founders ~ Nabajyoti Das, Pankaj Mazumder and Bapan Biswas. It is a smart queue management web-based application that enables people to make appointments with their doctors as well as inform them about the time to reach the clinics. In this process, it both saves patients from standing in long queues and increase chances of getting infected as well as saves time.
How it works?
Nabajyoti Das, aged 30, said patients can self register and request for appointment OXY QR (A personalized QR code for clinics/OPDs). As soon as the appointment is accepted by the clinic the patient can track the appointment slot in real time from anywhere and so there would be no need for waiting at the registration desk or outside the chamber. The best thing is that the patient can track his slot number and also know the patient’s number, which was being examined by the doctor at that particular time, he said.
How can vaccination centres benefit from Oxyfind?
“Currently, vaccination centres are facing a huge rush and people are seen queuing up to get their doses, giving physical distancing a toss. We can implement Oxyfind in the vaccination centres so that people won’t need to crowd at the centres. There is no need for any dedicated hardware to run this application. The only requirement is a smart phone with internet connection. We are contacting all non government organizations that are connected with the vaccination drive and are trying to make the process smooth. We are offering Oxyfind free of cost to them,” 28-year old Pankaj Mazumder told chalgenius.com.
Read this: Entrepreneurs of Kolkata join hands to set-up over 500 hospital beds for people in dire need during pandemic
The story behind Oxyfind
Initially the trio made a clinic management application where they tried saving Medical Record Database (MRDB) of patients. The application had Google Speech to Text API, enabling doctors to dictate the prescription aloud, while artificial intelligence (AI) typed it out for the patient. In October 2019, the team visited Bengaluru to pitch their idea for an event, and met a few people at NASSCOM. “An individual asked us to define the problem we were trying to solve in three to four words. That was an eye-opener for us,” Pankaj said. On returning to their hometown in Guwahati, the trio started redesigning the application. Oxyfind was thus launched in January 2020.
It is already benefiting people of Assam
Oxyfind was registered in June 2020. It is already working with 10 to 15 clinics and hospitals in Guwahati and Jorhat. The best thing about the application is that it takes only 10 to 15 minutes to work. It is incubated in IIM Calcutta Innovation Park and has got a grant from the Ministry of Electronics and Information Technology.
Get in touch!
Nabajyoti Das
Co-founder, Oxyfind
8723869242
Keywords: chalgenius, start-ups, Assam, Oxyfind, Assam, IIM Calcutta, Bengaluru, Covid
Follow us on Facebook, Linkedin and Instagram to get timely updates about start-ups
What kind articles you want to see in our website. Please mail us at gurvinder@chalgenius.com
You also want to feature your start-ups here. No Worries. Call or whatsapp at 8910430165. Please click to know more about us
Chalgenius is not just a media site. It creates more business opportunities for you by connecting you with thousands of potential customers, investors, accelerators and mentors across the country. Come grow your business with us. Contact us at 8910430165 or mail at chalgeniusss@gmail.com for further details.
Please subscribe our YouTube channel and like our Facebook page to know more about such inspiring startups.
Get more stuff like this
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
